Business Context and Reporting Period
Company: Inmune Bio, Inc. (INMB)
Filing Type: Form 8-K (Current Report)
Date of Report: September 3, 2024
Reporting Period: Event date of September 3, 2024
The filing serves as a current report to announce a scheduled corporate event rather than a periodic financial report. The Company is an emerging growth company incorporated in Nevada.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is limited to the announcement of a conference presentation.
Material Changes
No material financial changes or operational updates are reported in this filing. The sole material event is the confirmation of the Company's participation in an upcoming industry conference.
Guidance, Outlook, and Management Commentary
- Upcoming Event: Inmune Bio, Inc. will present at the Baird 2024 Global Healthcare Conference.
- Event Dates: September 10-11, 2024.
- Management Commentary: The filing references a press release (Exhibit 99.1) for further details but contains no specific guidance, risk factors, or contingencies within the text of the 8-K itself.
Investor Verification Checklist
- Verify the content of the attached press release (Exhibit 99.1) for specific details on the presentation topic.
- Confirm the schedule and access details for the Baird 2024 Global Healthcare Conference (September 10-11, 2024).
- Review the Company's most recent 10-Q or 10-K for actual financial performance metrics, as this 8-K contains none.